Douglas Thomson
Direktor/Vorstandsmitglied bei Nascient Ltd.
Profil
Douglas Campbell Thomson currently works at Nascient Ltd., as Director from 2016 and Pneumagen (Holdings) Ltd., as Director from 2020.
Aktive Positionen von Douglas Thomson
| Unternehmen | Position | Beginn |
|---|---|---|
Nascient Ltd.
 Nascient Ltd. BiotechnologyHealth Technology Nascient Ltd. develops a novel antibody treatment for rheumatoid arthritis. The company was founded by Phil Bland-Ward, Kim Midwood and Nigel Robert Burns in 2012 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 13.04.2016 |
| Pneumagen (Holdings) Ltd. | Direktor/Vorstandsmitglied | 23.04.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Nascient Ltd.
Nascient Ltd. BiotechnologyHealth Technology Nascient Ltd. develops a novel antibody treatment for rheumatoid arthritis. The company was founded by Phil Bland-Ward, Kim Midwood and Nigel Robert Burns in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
| Pneumagen (Holdings) Ltd. |
